:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
bio chat
Yogesh Mudras, Managing
Director, UBM India
industry which is
anticipated as the game
changer for the
industry.
Currently, India has
only 2.8 percent share
in the global
biopharmaceutical
market and the new
mission by the
Government of India
would elevate this to
5% resulting in an
additional business
opportunity of 16
Billion USD.
Government is
committed to make
India a hub for
development of
affordable and effective
biopharmaceutical
products and aspires to
create an enabling
ecosystem to promote
entrepreneurship and
indigenous
manufacturing in the
sector with Innovate in
India (i3) mission.
Furthermore, it will
also boost the growth
curve for domestic
BioVoiceNews.com
41